Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to Consider.

Lévesque E, Kirby E, Bolt I, Knoppers BM, de Beaufort I, Pashayan N, Widschwendter M.

Public Health Genomics. 2018 Sep 17:1-8. doi: 10.1159/000492663. [Epub ahead of print]

PMID:
30223261
2.

National Database for Autism Research (NDAR): Big Data Opportunities for Health Services Research and Health Technology Assessment.

Payakachat N, Tilford JM, Ungar WJ.

Pharmacoeconomics. 2016 Feb;34(2):127-38. doi: 10.1007/s40273-015-0331-6.

3.

Information technology and precision medicine.

Carney PH.

Semin Oncol Nurs. 2014 May;30(2):124-9. doi: 10.1016/j.soncn.2014.03.006. Review.

PMID:
24794086
4.

Opportunities for genomic clinical decision support interventions.

Overby CL, Kohane I, Kannry JL, Williams MS, Starren J, Bottinger E, Gottesman O, Denny JC, Weng C, Tarczy-Hornoch P, Hripcsak G.

Genet Med. 2013 Oct;15(10):817-23. doi: 10.1038/gim.2013.128. Epub 2013 Sep 19. No abstract available.

5.

Economic opportunities and challenges for pharmacogenomics.

Deverka PA, Vernon J, McLeod HL.

Annu Rev Pharmacol Toxicol. 2010;50:423-37. doi: 10.1146/annurev.pharmtox.010909.105805. Review.

PMID:
20055709
6.

Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges.

Avard D, Bridge P, Bucci LM, Chiquette J, Dorval M, Durocher F, Easton D, Godard B, Goldgar D, Knoppers BM, Laframboise R, Lespérance B, Plante M, Tavtigian SV, Vézina H, Wilson B; INHERIT BRCAs, Simard J.

Fam Cancer. 2006;5(1):3-13. Review.

PMID:
16528603
7.

Proteomics: from basic research to diagnostic application. A review of requirements & needs.

Vitzthum F, Behrens F, Anderson NL, Shaw JH.

J Proteome Res. 2005 Jul-Aug;4(4):1086-97. Review.

PMID:
16083257

Supplemental Content

Loading ...
Support Center